Davis Krista 4

What Happened

• Krista Davis, SVP and Chief HR Officer of ANI Pharmaceuticals (ANIP), had shares withheld to cover tax obligations when restricted stock vested. Two withholding transactions occurred: 1,180 shares withheld at $76.70 (=$90,506) and 1,290 shares withheld at $77.36 (=$99,794), totaling 2,470 shares and roughly $190,300. These were tax-withholding actions (transaction code F), not open-market sales or purchases.

Key Details

• Transaction dates and prices:
  • 2026-02-12: 1,180 shares withheld @ $76.70 — $90,506
  • 2026-02-14: 1,290 shares withheld @ $77.36 — $99,794
• Total shares withheld: 2,470; total value ≈ $190,300.
• Footnotes: Withholdings were to satisfy taxes on RSU vestings exempt under Rule 16(b)-3:
  • F1 relates to the vesting of 3,264 restricted shares (grant reported 2025-02-18).
  • F2 relates to the vesting of 3,020 restricted shares (grant reported 2024-02-16).
• Shares owned after the transactions: not specified in the provided filing excerpt.
• Filing timeliness: Report filed 2026-02-17 for transactions on 2026-02-12/14 — one business day late relative to the typical Form 4 two-business-day reporting requirement.

Context

• These entries reflect routine tax-withholding tied to restricted stock vesting (a common administrative action) rather than discretionary open-market sales or purchases. Such withholdings reduce the number of shares delivered to the insider to cover tax liabilities and do not necessarily indicate a change in the insider’s view of the company.